Conditions Treated by this Doctor:
Acute Lymphocytic Leukemia (ALL), Aplastic Anaemia, Chronic lymphocytic leukemia, Chronic Myeloid Leukemia, Deep Vein Thrombosis, Deep Vein Thrombosis, Essential Thrombocythemia and Myelofibrosis, Multiple Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Polycythemia Vera, Thalassemia.
Dr Ong graduated from Duke University, Durham, USA, with a Bachelor of Science in Biomedical and Electrical Engineering in 2004 with a Summa Cum Laude and completed a Masters of Science in Biomedical Engineering at Johns Hopkins University, Baltimore, USA in 2006 with a thesis entitled the hepatic differentiation potential of human mesenchymal stem cells. She then worked for 2.5 years as a research engineer, developing wound dressing and coordinating clinical trials with the USA Naval Research Medical Center before joining Duke-NUS Graduate Medical School and graduating in 2012 with the Singhealth Seah Cheng Siang Gold Medal, awarded to the best student in Internal Medicine. After completing Junior Residency in Internal Medicine and Senior Residency in Haematology, she is now a Consultant since November 2020 with a subspecialty focus on Lymphoma and Flow Cytometry. She has obtained her membership from the Royal College of Physicians of the United Kingdom in 2014 and Royal College of Pathologists of the United Kingdom in 2017. She is actively involved in investigator and pharmaceutical sponsored trials for lymphoma and myeloma and published several papers in peer reviewed journals. In 2020, Dr Ong received the HMDP award for a fellowship in Personalised Immunotherapy in Stanford University, USA. Her career goals are to improve treatment outcomes for lymphoma and to improve flow cytometry diagnostics.